Literature DB >> 32971178

Advances in drug delivery systems: Work in progress still needed?

Flavia Laffleur1, Valérie Keckeis2.   

Abstract

A new era of science and technology has emerged in pharmaceutical research with focus on developing novel drug delivery systems for oral administration. Conventional dosage forms like tablets and capsules are associated with a low bioavailability, frequent application, side effects and hence patient noncompliance. By developing novel strategies for drug delivery, researchers embraced an alternative to traditional drug delivery systems. Out of those, fast dissolving drug delivery systems are very eminent among pediatrics and geriatrics. Orally disintegrating films are superior over fast dissolving tablets as the latter are assigned with the risk of suffocation. Due to their ability of bypassing the dissolution and the first pass effect after oral administration, self-emulsifying formulations have also become increasingly popular in improving oral bioavailability of hydrophobic drugs. Osmotic devices enable a controlled drug delivery independent upon gastrointestinal conditions using osmosis as driving force. The advances in nanotechnology and the variety of possible materials and formulation factors enable a targeted delivery and triggered release. Vesicular systems can be easily modified as required and provide a controlled and sustained drug delivery to a specific site. This work provides an insight of the novel approaches in drug delivery covering the critical comparison between traditional and novel "advanced-designed" systems.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Fast dissolving; Nanoparticulate; Osmotic; Selfemulsifying; Vesicular

Mesh:

Substances:

Year:  2020        PMID: 32971178     DOI: 10.1016/j.ijpharm.2020.119912

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

Review 1.  The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical Implications.

Authors:  Amir Hossein Miri; Mojtaba Kamankesh; Antoni Llopis-Lorente; Chenguang Liu; Matthias G Wacker; Ismaeil Haririan; Hamid Asadzadeh Aghdaei; Michael R Hamblin; Abbas Yadegar; Mazda Rad-Malekshahi; Mohammad Reza Zali
Journal:  Front Pharmacol       Date:  2022-06-27       Impact factor: 5.988

Review 2.  Nanocarriers for anticancer drugs: Challenges and perspectives.

Authors:  Amany I Alqosaibi
Journal:  Saudi J Biol Sci       Date:  2022-04-22       Impact factor: 4.052

Review 3.  Advances in Nano-Enabled Platforms for the Treatment of Depression.

Authors:  Fadzai P Mutingwende; Pierre P D Kondiah; Philemon Ubanako; Thashree Marimuthu; Yahya E Choonara
Journal:  Polymers (Basel)       Date:  2021-04-29       Impact factor: 4.329

Review 4.  A Revolutionary Blueprint for Mitigation of Hypertension via Nanoemulsion.

Authors:  Girish Kumar; Tarun Virmani; Kamla Pathak; Abdulsalam Alhalmi
Journal:  Biomed Res Int       Date:  2022-04-14       Impact factor: 3.246

Review 5.  Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines.

Authors:  Thai Thanh Hoang Thi; Estelle J A Suys; Jung Seok Lee; Dai Hai Nguyen; Ki Dong Park; Nghia P Truong
Journal:  Vaccines (Basel)       Date:  2021-04-08

6.  Active Carboxymethylcellulose-Based Edible Films: Influence of Free and Encapsulated Curcumin on Films' Properties.

Authors:  Ana I Bourbon; Maria J Costa; Luís C Maciel; Lorenzo Pastrana; António A Vicente; Miguel A Cerqueira
Journal:  Foods       Date:  2021-06-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.